Home β€Ί Healthcare β€Ί Biotechnology β€Ί Recombinant DNA Technology Market

Recombinant DNA Technology Market - Strategic Insights and Forecasts (2026-2031)

πŸ“₯ Download Free SampleπŸ’¬ Speak to Analyst
$3,950
Single User License
Access Full Insights
Report OverviewSegmentationTable of ContentsCustomize Report

Table of Contents

1.  INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY  

2.1. Research Data

2.2. Assumptions

3. EXECUTIVE SUMMARY

3.1. Research Highlights

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Force Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

5. RECOMBINANT DNA TECHNOLOGY MARKET, BY PRODUCT

5.1. Introduction

5.2. Medical

5.3. Non-medical

6. RECOMBINANT DNA TECHNOLOGY MARKET, BY COMPONENT

6.1. Introduction

6.2. Expression System

6.3. Cloning Vector

7. RECOMBINANT DNA TECHNOLOGY MARKET, BY APPLICATION

7.1. Introduction

7.2. Food & Agriculture

7.3. Health & Disease

7.4. Environment

7.5. Others

8. RECOMBINANT DNA TECHNOLOGY MARKET, BY END-USE

8.1. Introduction

8.2. Biotechnology and Pharmaceutical Companies

8.3. Academic and Government Research Institutes

8.4. Others

9. RECOMBINANT DNA TECHNOLOGY MARKET, BY GEOGRAPHY

9.1. Introduction

9.2. North America

9.2.1. United States

9.2.2. Canada

9.2.3. Mexico

9.3. South America

9.3.1. Brazil

9.3.2. Argentina

9.3.3. Others

9.4. Europe

9.4.1. United Kingdom

9.4.2. Germany

9.4.3. France

9.4.4. Spain

9.4.5. Others

9.5. The Middle East and Africa

9.5.1. Saudi Arabia

9.5.2. UAE

9.5.3. Israel

9.5.4. Others

9.6. Asia Pacific

9.6.1. Japan

9.6.2. China

9.6.3. India

9.6.4. South Korea

9.6.5. Indonesia

9.6.6. Thailand

9.6.7. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

10.1. Major Players and Strategy Analysis

10.2. Market Share Analysis

10.3. Mergers, Acquisitions, Agreements, and Collaborations

10.4. Vendor Competitiveness Matrix

11. COMPANY PROFILES 

11.1. MBL Life Science

11.2. Sino Biological Inc.

11.3. Genentech

11.4. Prospec

11.5. Thermo Fisher Scientific

11.6. Biomay AG

11.7. ElabScience

11.8. Promega

11.9. Xpress Biologics

12. RESEARCH METHODOLOGY

LIST OF FIGURES

LIST OF TABLES

REPORT DETAILS

Report ID:KSI061616035
Published:Jan 2026
Pages:150
Format:PDF, Excel, PPT, Dashboard
πŸ“₯ Download SampleπŸ“ž Speak to AnalystπŸ“§ Request Customization

Need Assistance?

Our research team is available to answer your questions.

Contact Us